💰The Funding Letter #1282: November 3

Terremoto Biosciences, Viably, Xage Security, and more...

November 03, 2023

Happy Friday! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City. Have a great weekend!

Hit the Gong 🎉

Source: @life.long.sdr

Daily Deals 💸

🌎 Americas

Terremoto Biosciences has developed a drug discovery platform that can deliver medicines with optimized clinical profiles and superior therapeutic benefits, enabling healthcare sector businesses to improve current medicines and create new, effective therapies. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $175M, Series B

Round Investors: Cormorant Capital, EcoR1 Capital, Novo Holdings, Third Rock Ventures

🚀Growth Focus: Advance its platform and support the progress of multiple in-house discovery and development programs targeting diseases of high unmet medical need.

HQ: San Francisco, CA

Industry: Biotechnology Research

Employee Count: 38

Subscribe to TFL All-Access Tier to read the rest.

Become a paying subscriber of TFL All-Access Tier to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In.

A subscription gets you:

  • • Exclusive Access to The Funding Letter, delivering hundreds of leads to your inbox each month
  • • Searchable weekly, monthly, and annual datasets of funding announcement leads, so you can quickly find the most relevant data
  • • The hottest Sales Gigs in the industry, sourced from the fastest growing startups
  • • ..and much more to come!